Cole KA, Ijaz H, Surrey LF, Santi M, et al. Pediatric phase 2 trial of a WEE1 inhibitor, adavosertib (AZD1775), and irinotecan for relapsed neuroblastoma, medulloblastoma, and rhabdomyosarcoma. Cancer 2023 Apr 20. doi: 10.1002/cncr.34786.
PMID: 37081608